Hit and lead generation: beyond high-throughput screening (original) (raw)

• Drews, J. Drug discovery: A historical perspective. Science 287, 1960–1964 (2000).
  Article CAS Google Scholar
• Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
  Article CAS Google Scholar
• Knowles, J. & Gromo, G. Target selection in drug discovery. Nature Rev. Drug Discov. 2, 63–69 (2003).
  Article CAS Google Scholar
• Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 727–730 (2002).
  Article CAS Google Scholar
• Lenz, G. R., Nash, H. M. & Jindal, A. Chemical ligands, genomics and drug discovery. Drug Discov. Today 5, 145–156 (2000).
  Article CAS Google Scholar
• Hodgson, J. ADMET — turning chemicals into drugs. Nature Biotechnol. 19, 722–726 (2001).
  Article CAS Google Scholar
• Proudfoot, J. R. Drugs, leads, and drug-likeness: An analysis of some recently launched drugs. Bioorg. Med. Chem. Lett. 12, 1647–1650 (2002).
  Article CAS Google Scholar
• Alanine, A., Nettekoven, M., Roberts, E. & Thomas, A. Lead generation — enhancing the success of drug discovery by investing into the hit to lead process. Combin. Chem. High Throughput Screen. 6, 51–66 (2003).
  Article CAS Google Scholar
• Boguslavsky, J. Minimizing risk in 'Hits to Leads'. Drug Discov. & Develop. 4, 26–30 (2001).
  Google Scholar
• Bleicher, K. H. Chemogenomics: bridging a drug discovery gap. Curr. Med. Chem. 9, 2077–2084 (2002).
  Article CAS Google Scholar
• Bajorath, J. Integration of virtual and high-throughput screening. Nature Rev. Drug Discov. 1, 882–894 (2002). This review article covers the current concepts of integrating both virtual and high-throughput screening.
  Article CAS Google Scholar
• Teague, J. S., Davis, A. M., Leeson, P. D. & Oprea, T. The design of leadlike combinatorial libraries. Angew. Chem. Int. Ed. Engl. 38, 3743–3748 (1999).
  Article CAS Google Scholar
• Walters, P. & Murcko, M. A. Prediction of 'drug-likeness' Adv. Drug Deliv. Rev. 54, 255–271 (2002).
  Article CAS Google Scholar
• Martin, E. J. & Critchlow, R. E. Beyond mere diversity: tailoring combinatorial libraries for drug discovery. J. Comb. Chem. 1, 32–45 (1999).
  Article CAS Google Scholar
• Menard, P. R., Mason, J. S., Morize I. & Bauerschmidt, S. Chemistry space metrics in diversity analysis, library design and compound selection. J. Chem. Inf. Comput. Sci. 38, 1204–1213 (1998).
  Article CAS Google Scholar
• Roche, O. et al. Development of a virtual screening method for identification of 'Frequent Hitters' in compound libraries. J. Med. Chem. 45, 137–142 (2002).
  Article CAS Google Scholar
• Balkenhohl, F., von dem Busche-Hünnefeld, C., Lansky, A. & Zechel, C. Combinatorial synthesis of small organic molecules. Angew. Chem. Int. Ed. Engl. 35, 2288–2337 (1996).
  Article CAS Google Scholar
• Böhm, H. -J. & Schneider, G. (eds). Virtual Screening for Bioactive Molecules (Wiley–VCH, Weinheim, 2000). An excellent compendium of current virtual screening methods.
  Book Google Scholar
• Hann, M. M., Leach, A. R. & Harper, G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J. Chem. Inf. Comput. Sci. 41, 856–864 (2001).
  Article CAS Google Scholar
• Crossley, R. From hits to leads, focusing the eyes of medicinal chemistry. Modern Drug Discov. 5, 18–22 (2002).
  CAS Google Scholar
• Van Dogen, M., Weigelt, J., Uppenberg, J., Schultz, J. & Wikström, M. Structure-based screening and design in drug discovery. Drug Discov. Today 7, 471–477 (2002).
  Article Google Scholar
• Carr, R. & Jhoti, H. Structure-based screening of low affinity compounds. Drug Discov. Today 7, 522–527 (2002).
  Article CAS Google Scholar
• Huang, L., Lee, A. & Ellman, J. A. Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis. J. Med. Chem. 45, 676–684 (2002).
  Article CAS Google Scholar
• Patchett, A. A. & Nargund, R. P. Privileged structures — an update. Annu. Rep. Med. Chem. 35, 289–298 (2000).
  CAS Google Scholar
• Bleicher, K. H., Wütherich, Y., Adam, G., Hoffmann, T. & Sleight, A. J. Parallel solution- and solid-phase synthesis of spiropyrrolo-pyrroles as novel NK-1 receptor ligands. Bioorg. Med. Chem. Lett. 12, 3073–3076 (2002).
  Article CAS Google Scholar
• Stahl, M. et al. A validation study on the practical use of automated de novo design. J. Comput.-Aided Mol. Des. 16, 459–478 (2002).
  Article CAS Google Scholar
• Schneider, G. et al. Virtual screening for bioactive molecules by de novo design. Angew. Chem Int. Ed. Engl. 39, 4130–4133 (2000).
  Article CAS Google Scholar
• Schneider, G. & Böhm, H. -J. Virtual screening and fast automated docking methods. Drug Discov. Today 7, 64–70 (2002).
  Article CAS Google Scholar
• Lipinski, C., Lombardo, F., Dominy, B. & Feeney, P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3–25 (1997). A landmark publication based on retrospective data analysis for bioavailability resulting in the 'rule-of-five'.
  Article CAS Google Scholar
• Cariello, N. F. et al. Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Mutagenesis 17, 321–329 (2002).
  Article CAS Google Scholar
• Sadowski, J. & Kubinyi, H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 41, 3325–3329 (1998).
  Article CAS Google Scholar
• Zuegge, J. et al. A fast virtual screening filter for cytochrome P450 3A4 inhibition liability of compound libraries. Quant. Struct.-Act. Relat. 21, 249–256 (2002).
  Article CAS Google Scholar
• Roche, O. et al. A virtual screening method for prediction of the hERG potassium channel liability of compound libraries. Chembiochem 3, 455–459 (2002).
  Article CAS Google Scholar
• Schneider, G., Neidhart, W., Giller, T. & Schmid, S. 'Scaffold hopping' by topological pharmacophore search: a contribution to virtual screening. Angew. Chem Int. Ed. Engl. 38, 2894–2896 (1999).
  Article CAS Google Scholar
• Mason, J. S., Good, A. C. & Martin, E. J. 3-D Pharmacophores in drug discovery. Curr. Pharm. Des. 7, 567–597 (2001).
  Article CAS Google Scholar
• Bissantz, C., Folkers, G. & Rognan, D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J. Med. Chem. 43, 4759–4767 (2000).
  Article CAS Google Scholar
• Duckworth, D. M. & Sanseau, P. In silico identification of novel therapeutic targets. Drug Discov. Today 7, 64–69 (2002).
  Article Google Scholar
• Lee, D. K. et al. Identification of four human G-protein-coupled receptors expressed in the brain. Mol. Brain Res. 86, 13–22 (2001). This paper describes the successful identification of orphan G-protein-coupled receptors initiated by bioinformatic approaches.
  Article CAS Google Scholar
• Alaimo, P. J., Shogren-Knaak, M. A. & Shokat, K. M. Chemical genetic approaches for the elucidation of signaling pathways. Curr. Opin. Chem. Biol. 5, 360–367 (2001).
  Article CAS Google Scholar
• McGregor, M. J. & Pallai, P. V. Clustering of large databases of compounds: using the MDL “keys” as structural descriptors. J. Chem. Inf. Comp. Sci. 37, 443–448 (1997).
  Article CAS Google Scholar
• Stanton, D. T. Evaluation and use of BCUT descriptors in QSAR and QSPR studies. J. Chem. Inf. Com. Sci. 39, 11–20 (1999).
  Article CAS Google Scholar
• Sprague, P. W. Automated chemical hypothesis generation and database searching with CATALYST. Perspect. Drug Discov. Design 3, 1–20 (1995).
  Article CAS Google Scholar
• Liebeschuetz, J. W. et al. PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective Factor Xa inhibitors. J. Med. Chem. 45, 1221–1232 (2002).
  Article CAS Google Scholar
• Boehm, H. -J. Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J. Comput.-Aided Mol. Des. 12, 309–323 (1998).
  Article Google Scholar